4 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow Hypersomnia: new trials by email Literature Review of Hypersomnia trials Research Report on Hypersomnia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia) Modafinil, Modafinil Placebo, Solriamfetol - Long COVID, Long COVID-19 | Phase 2 | Completed | Duke University | 361 | 2024-08-12 | 2026-06-03 |
| RECOVER-SLEEP: Platform Protocol Modafinil, Modafinil Placebo, Solriamfetol - Long COVID, Long COVID-19 | Phase 2 | Completed | Duke University | 830 | 2024-07-31 | 2026-01-22 |
| Flumazenil for the Treatment of Primary Hypersomnia Flumazenil - Hypersomnia, Primary Hypersomnia | Phase 1 / Phase 2 | Completed | Lynn Marie Trotti | 10 | 2010-09-01 | 2017-12-12 |
| Clarithromycin for the Treatment of Hypersomnia Clarithromycin followed by placebo, Placebo then Clarithromycin - Hypersomnia, Idiopathic Hypersomnia | Phase 2 | Completed | Lynn Marie Trotti | 26 | 2010-07-01 | 2017-11-06 |
Disorders of Excessive Somnolence (4) · Idiopathic Hypersomnia (2) · Post-Acute COVID-19 Syndrome (2) · Narcolepsy (1) · Parasomnias (1)
Dyssomnias (4) · Mental Disorders (4) · Nervous System Diseases (4) · Sleep Disorders, Intrinsic (4) · Sleep Wake Disorders (4) · COVID-19 (2) · Chronic Disease (2) · Coronaviridae Infections (2) · Coronavirus Infections (2) · Disease Attributes (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Modafinil (2) · solriamfetol (2) · Clarithromycin (1) · Flumazenil (1) · Melatonin (1)
Duke University (2) · Lynn Marie Trotti (2)
United States (4)
Christina Barkauskas, MD (2) · Lynn Marie Trotti, MD (2) · Susan Redline, MD MPH (2)